Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease

Connective tissue diseases (CTDs) are an important secondary cause of interstitial lung disease (ILD). If a CTD is suspected, clinicians are recommended to perform autoantibody testing, including for myositis autoantibodies. In this study, the prevalence and clinical associations of novel myositis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Moll, Sofia A., Platenburg, Mark G. J. P., Platteel, Anouk C. M., Vorselaars, Adriane D. M., Janssen Bonàs, Montse, Roodenburg-Benschop, Claudia, Meek, Bob, van Moorsel, Coline H. M., Grutters, Jan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563342/
https://www.ncbi.nlm.nih.gov/pubmed/32933078
http://dx.doi.org/10.3390/jcm9092944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563342/
https://www.ncbi.nlm.nih.gov/pubmed/32933078
http://dx.doi.org/10.3390/jcm9092944

Ejemplares similares